Skip to main content
. Author manuscript; available in PMC: 2022 May 2.
Published in final edited form as: J Immunol. 2022 Apr 4;208(8):1968–1977. doi: 10.4049/jimmunol.2101099

Figure 6. Downstream analysis of altered genes in COVID-19 patients.

Figure 6.

The downstream analysis was performed using Qiagen Ingenuity Pathway Analysis. More than one third of upregulated genes are downstream targets of dexamethasone.